Evidence map›Paper›PMID 37296226›Full record

ArticleCommunications biology2023

Y chromosome sequence and epigenomic reconstruction across human populations.

Paula Esteller-Cucala, Marc Palmada-Flores, Lukas F K Kuderna, Claudia Fontsere, Aitor Serres-Armero, Marc Dabad, María Torralvo, Armida Faella, Luis Ferrández-Peral, Laia Llovera and 8 more

Abstract read
In one paragraph

Article in Communications biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Paula Esteller-Cucala *Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain. paula.esteller@upf.edu.ORCID 0000-0003-3048-4280
Marc Palmada-Flores *Institut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Lukas F K KudernaInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Claudia FontsereInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Aitor Serres-ArmeroInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Marc DabadCNAG-CRG, Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Baldiri i Reixac 4, Barcelona, Spain.ORCID 0000-0002-6094-747X
María TorralvoInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.ORCID 0000-0003-2267-1406
Armida FaellaInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Luis Ferrández-PeralInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Laia LloveraInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Oscar FornasCentre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain.ORCID 0000-0003-2017-9100
Eva JuliàCentre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain.ORCID 0000-0002-9722-4662
Erika RamírezCentre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain.
Irene GonzálezCentre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain.
Jochen HechtCentre for Genomic Regulation (CRG), Barcelona Institute for Science and Technology (BIST), Doctor Aiguader 88, Barcelona, Spain.
Esther LizanoInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.ORCID 0000-0003-3304-9807
David JuanInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain.
Tomàs Marquès-BonetInstitut de Biologia Evolutiva (CSIC-Universitat Pompeu Fabra), Doctor Aiguader 88, Barcelona, Spain. tomas.marques@upf.edu.ORCID 0000-0002-5597-3075

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in long-read sequencing technologies have allowed the generation and curation of more complete genome assemblies, enabling the analysis of traditionally neglected chromosomes, such as the human Y chromosome (chrY). Native DNA was sequenced on a MinION Oxford Nanopore Technologies sequencing device to generate genome assemblies for seven major chrY human haplogroups. We analyzed and compared the chrY enrichment of sequencing data obtained using two different selective sequencing approaches: adaptive sampling and flow cytometry chromosome sorting. We show that adaptive sampling can produce data to create assemblies comparable to chromosome sorting while being a less expensive and time-consuming technique. We also assessed haplogroup-specific structural variants, which would be otherwise difficult to study using short-read sequencing data only. Finally, we took advantage of this technology to detect and profile epigenetic modifications among the considered haplogroups. Altogether, we provide a framework to study complex genomic regions with a simple, fast, and affordable methodology that could be applied to larger population genomics datasets.

Indexed as

EpigenomicsHigh-Throughput Nucleotide SequencingGenomicsHumansSequence Analysis, DNAY Chromosome

Identifiers

PMID37296226
PMCPMC10256797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.